mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.6 |